CLL: Treatment and Management Strategies for Best Outcomes - Episode 9
Yuliya Linhares, MD, discusses the CLL14 study, which is looking at venetoclax plus obinutuzumab in patients with previously untreated chronic lymphocytic leukemia.
Related Content:
Finally Learning to Put Myself First
Experts Discuss Next Steps in Perioperative Bladder Cancer Treatment
Signatera Guides Bladder Cancer Treatment After Surgery
What If? Embracing Hope During a Cancer Journey